Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1998 4
1999 2
2000 3
2001 6
2003 1
2004 2
2018 1
2019 1
2020 1
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition and induction of human cytochrome P450 (CYP) enzymes.
Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H. Pelkonen O, et al. Among authors: taavitsainen p. Xenobiotica. 1998 Dec;28(12):1203-53. doi: 10.1080/004982598238886. Xenobiotica. 1998. PMID: 9890159 Review. No abstract available.
First-in-Class Small Molecule to Inhibit CYP11A1 And Steroid Hormone Biosynthesis.
Karimaa M, Riikonen R, Kettunen H, Taavitsainen P, Ramela M, Chrusciel M, Karlsson S, Rummakko P, Simola O, Wohlfahrt G, Hakulinen P, Vuorela A, Joensuu H, Utriainen T, Fizazi K, Oksala R. Karimaa M, et al. Among authors: taavitsainen p. Mol Cancer Ther. 2022 Sep 21:MCT-22-0115. doi: 10.1158/1535-7163.MCT-22-0115. Online ahead of print. Mol Cancer Ther. 2022. PMID: 36129801
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1.
Oksala R, Moilanen A, Riikonen R, Rummakko P, Karjalainen A, Passiniemi M, Wohlfahrt G, Taavitsainen P, Malmström C, Ramela M, Metsänkylä HM, Huhtaniemi R, Kallio PJ, Mustonen MV. Oksala R, et al. Among authors: taavitsainen p. J Steroid Biochem Mol Biol. 2019 Sep;192:105115. doi: 10.1016/j.jsbmb.2018.02.004. Epub 2018 Feb 10. J Steroid Biochem Mol Biol. 2019. PMID: 29438723 Free article.
CYP2D6 polymorphism is not crucial for the disposition of selegiline.
Scheinin H, Anttila M, Dahl ML, Karnani H, Nyman L, Taavitsainen P, Pelkonen O, Bertilsson L. Scheinin H, et al. Among authors: taavitsainen p. Clin Pharmacol Ther. 1998 Oct;64(4):402-11. doi: 10.1016/S0009-9236(98)90071-6. Clin Pharmacol Ther. 1998. PMID: 9797797 Clinical Trial.
25 results